TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma.

Brian A Van Tine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.